Recent Life Sciences Deal Trends
Andrew Merken, Shareholder in our Venture Capital and Emerging Growth Companies Group, analyzes recent trends and future projections in life sciences transactions, including venture capital financing, M&A, licensing agreements and initial public offerings from 2020 to 2025.
